Aspen Pharmacare Holdings Ltd.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: ZAE000066692

ZAR

97.48

0.97 (1.01%)

Dec 19

JSE

Click here to see other stocks

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.43 M

Shareholding (Dec 2023)

FII

0.01%

Held by 1 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.38%

Poor long term growth as Net Sales has grown by an annual rate of 2.33% and Operating profit at -3.68% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

With ROE of 5.94%, it has a Very Expensive valuation with a 0.53 Price to Book Value

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

ZAR 41,051 Million ()

P/E

9.00

Industry P/E

Dividend Yield

0.14%

Debt Equity

0.35

Return on Equity

5.94%

Price to Book

0.48

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-4.31%

6 Months

-18.46%

1 Year

-41.09%

2 Years

-50.02%

3 Years

-28.32%

4 Years

-56.71%

5 Years

-24.09%

Aspen Pharmacare Holdings Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

2.33%

EBIT Growth (5y)

-3.68%

EBIT to Interest (avg)

8.55

Debt to EBITDA (avg)

2.11

Net Debt to Equity (avg)

0.34

Sales to Capital Employed (avg)

0.38

Tax Ratio

25.25%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.01%

ROCE (avg)

9.38%

ROE (avg)

8.56%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.53

EV to EBIT

9.19

EV to EBITDA

7.31

EV to Capital Employed

0.65

EV to Sales

1.72

PEG Ratio

Dividend Yield

0.13%

ROCE (Latest)

7.12%

ROE (Latest)

5.94%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2023

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Aspen Pharmacare Holdings Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Aspen Pharmacare Holdings Ltd."
  }
]

Company CV

About

Company Coordinates

Company Details

Tel:

Registrar Details